RELIEF THERAPEUTICS N news, videos and press releases
For more news please use our advanced search feature.
RELIEF THERAPEUTICS N - More news...
RELIEF THERAPEUTICS N - More news...
- Relief Therapeutics Announces Implementation Timeline for Reverse Split of Ordinary Shares
- Relief Therapeutics Announces Implementation Timeline for Reverse Split of Ordinary Shares
- Relief Therapeutics Announces Collaboration Partner Reports OLPRUVA™ Commercial Launch Progressing Ahead of Schedule
- Relief Therapeutics Announces Collaboration Partner Reports OLPRUVA(TM) Commercial Launch Progressing Ahead of Schedule
- Relief Therapeutics Announces Results of Extraordinary General Meeting of Shareholders
- Relief Therapeutics Announces Results of Extraordinary General Meeting of Shareholders
- Relief Therapeutics Announces Positive 12-Month Stability Data for Inhaled and Intravenous Preparations of RLF-100
- Relief Therapeutics Announces Positive 12-Month Stability Data for Inhaled and Intravenous Preparations of RLF-100
- Relief Therapeutics Announces Full Year 2022 Financial Results and Provides Corporate Update
- Relief Therapeutics Announces Full Year 2022 Financial Results and Provides Corporate Update
- Relief Therapeutics Announces Executive Leadership Team Change
- Relief Therapeutics Announces Executive Leadership Team Change
- Relief Therapeutics Holding SA to Hold Extraordinary General Meeting of Shareholders
- Relief Therapeutics Holding SA to Hold Extraordinary General Meeting of Shareholders
- Relief Therapeutics Appoints World-Renowned Gene Therapy Pioneer Guangping Gao, Ph.D. as Chair of Scientific Advisory Board
- Relief Therapeutics Appoints World-Renowned Gene Therapy Pioneer Guangping Gao, Ph.D. as Chair of Scientific Advisory Board
- Relief Therapeutics Announces Survey Results Identifying Preferred Urea Cycle Disorder Treatment Attributes Presented by Collaboration Partner at SIMD 2023
- Relief Therapeutics Announces Survey Results Identifying Preferred Urea Cycle Disorder Treatment Attributes Presented by Collaboration Partner at SIMD 2023
- Relief Therapeutics to Present Pre-Clinical Evidence for Improved Amino Acid Utilization with PKU GOLIKE at the Society for Inherited Metabolic Disorders 44th Annual Meeting
- Relief Therapeutics to Present Pre-Clinical Evidence for Improved Amino Acid Utilization with PKU GOLIKE at the Society for Inherited Metabolic Disorders 44th Annual Meeting
- Relief Therapeutics Announces Availability of New PKU GOLIKE BARs in Europe
- Relief Therapeutics Announces Availability of New PKU GOLIKE BARs in Europe
- Relief Therapeutics Provides Update From Collaboration Partner on OLPRUVA™
- Relief Therapeutics Provides Update From Collaboration Partner on OLPRUVA
- Relief Therapeutics Recognizes Rare Disease Day and Announces U.S. Availability of New PKU GOLIKE Bars
- Relief Therapeutics Recognizes Rare Disease Day and Announces U.S. Availability of New PKU GOLIKE Bars
- Relief Therapeutics Announces Enrollment of First Three Patients in Proof-of-Concept Clinical Trial of RLF-TD011 for the Treatment of Epidermolysis Bullosa
- Relief Therapeutics Announces Enrollment of First Three Patients in Proof-of-Concept Clinical Trial of RLF-TD011 for the Treatment of Epidermolysis Bullosa
- Relief Therapeutics Provides an Update on its Financing Strategy
- Relief Therapeutics Provides an Update on its Financing Strategy
